SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?


To: Walter Morton who wrote (2071)4/23/1999 1:46:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
From the transaction section on Genome's web page>>>

This section is currently under development.  We will have information
posted shortly.  Please check back soon!



To: Walter Morton who wrote (2071)4/23/1999 1:50:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
Kenneth Starr's law firm(Kirkland and Ellis) has 250,000 options of Cistron stock at 50 cents.



To: Walter Morton who wrote (2071)4/23/1999 2:18:00 PM
From: Steve Harmon  Read Replies (2) | Respond to of 2742
 
Henry Grauz has been in Chapter 11 bankruptcy for quite a while now.

He owns 6 million shares of Cistron.

What is the maximum time he can be in Chapter 11?



To: Walter Morton who wrote (2071)4/23/1999 2:40:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
Walter,

I can't remember. Did Grauz resign or was he forced out by the bod?



To: Walter Morton who wrote (2071)4/23/1999 3:14:00 PM
From: Steve Harmon  Read Replies (2) | Respond to of 2742
 
Would it be more advantageous to Grauz for his 6 million shares to go up in value while in Chapter 11 or stay at these distressed levels?

Any Chapter 11 bankruptcy experts out there?



To: Walter Morton who wrote (2071)5/4/1999 4:41:00 PM
From: David Birman  Read Replies (2) | Respond to of 2742
 
Hey Walter, it is in support. I am a shareholder of Cistron, you might be interested in taking a look at Pharmex. When I first mentioned it it was 12 cents now it trades between 50 and 60. There is a research report expected out shortly around 2 dollars. We are in this together